These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 33771217)
1. Clinical validation of controlled exposure to house dust mite in the environmental exposure unit (EEU). Hossenbaccus L; Linton S; Thiele J; Steacy L; Walker T; Malone C; Ellis AK Allergy Asthma Clin Immunol; 2021 Mar; 17(1):34. PubMed ID: 33771217 [TBL] [Abstract][Full Text] [Related]
2. Clinical validation of controlled exposure to birch pollen in the Environmental Exposure Unit (EEU). Ellis AK; Soliman M; Steacy LM; Adams DE; Hobsbawn B; Walker TJ Allergy Asthma Clin Immunol; 2016; 12():53. PubMed ID: 27777594 [TBL] [Abstract][Full Text] [Related]
3. Clinical validation of controlled grass pollen challenge in the Environmental Exposure Unit (EEU). Ellis AK; Steacy LM; Hobsbawn B; Conway CE; Walker TJ Allergy Asthma Clin Immunol; 2015; 11(1):5. PubMed ID: 25653682 [TBL] [Abstract][Full Text] [Related]
4. Utility of silver birch and house dust mite extracts derived from licensed sublingual tablets for nasal allergen challenge. Olivieri B; Gil AJ; Stoenchev K; Durham SR; Scadding G Clin Transl Allergy; 2024 May; 14(5):e12360. PubMed ID: 38779783 [TBL] [Abstract][Full Text] [Related]
5. Biologic Responses to House Dust Mite Exposure in the Environmental Exposure Unit. Hossenbaccus L; Linton S; Thiele J; Steacy L; Walker T; Malone C; Ellis AK Front Allergy; 2021; 2():807208. PubMed ID: 35386971 [No Abstract] [Full Text] [Related]
6. Validated allergen exposure chamber is plausible tool for the assessment of house dust mite-triggered allergic rhinitis. Zemelka-Wiacek M; Kosowska A; Winiarska E; Sobanska E; Jutel M Allergy; 2023 Jan; 78(1):168-177. PubMed ID: 35980665 [TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial. Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432 [TBL] [Abstract][Full Text] [Related]
8. The Allergic Rhinitis - Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies. Ellis AK; Soliman M; Steacy L; Boulay MÈ; Boulet LP; Keith PK; Vliagoftis H; Waserman S; Neighbour H Allergy Asthma Clin Immunol; 2015; 11(1):16. PubMed ID: 25945101 [TBL] [Abstract][Full Text] [Related]
9. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit. Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967 [TBL] [Abstract][Full Text] [Related]
10. Nasal IgE in subjects with allergic and non-allergic rhinitis. Eckrich J; Hinkel J; Fischl A; Herrmann E; Holtappels G; Bachert C; Zielen S World Allergy Organ J; 2020 Jun; 13(6):100129. PubMed ID: 32612737 [TBL] [Abstract][Full Text] [Related]
11. Sodium Chloride versus Lactose as a Carrier for House Dust Mite Allergen in Allergen Chamber Studies: A Clinical Study to Assess Noninferiority. Struß N; Dieter S; Schwarz K; Badorrek P; Hohlfeld JM Int Arch Allergy Immunol; 2023; 184(11):1143-1152. PubMed ID: 37586347 [TBL] [Abstract][Full Text] [Related]
12. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber. Nolte H; Maloney J; Nelson HS; Bernstein DI; Lu S; Li Z; Kaur A; Zieglmayer P; Zieglmayer R; Lemell P; Horak F J Allergy Clin Immunol; 2015 Jun; 135(6):1494-501.e6. PubMed ID: 25636947 [TBL] [Abstract][Full Text] [Related]
14. Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber. Zemelka-Wiacek M; Kosowska A; Jutel M J Vis Exp; 2023 Mar; (193):. PubMed ID: 36939263 [TBL] [Abstract][Full Text] [Related]
15. Individual wearable air purifier protects against pollen, house dust mite, and cat allergens: Report from an allergen exposure chamber. Bergmann KC; Hartung T; Zuberbier T Allergol Select; 2024; 8():70-77. PubMed ID: 38549812 [TBL] [Abstract][Full Text] [Related]
16. Safety, efficacy and repeatability of a novel house dust mite allergen challenge technique in the Fraunhofer allergen challenge chamber. Lueer K; Biller H; Casper A; Windt H; Mueller M; Badorrek P; Haefner D; Framke T; Koch A; Ziehr H; Krug N; Koch W; Hohlfeld JM Allergy; 2016 Dec; 71(12):1693-1700. PubMed ID: 27255590 [TBL] [Abstract][Full Text] [Related]
17. Dual symptomatic and exudative nasal responses are not characteristics of perennial allergic rhinitis. Andersson M; Rimmer J; Salome C; Greiff L; Persson C Acta Otolaryngol; 2001 Apr; 121(3):407-13. PubMed ID: 11425210 [TBL] [Abstract][Full Text] [Related]
18. Environmental exposure unit simulates natural seasonal birch pollen exposures while maximizing change in allergic symptoms. Ellis AK; DeVeaux M; Steacy L; Ramesh D; Suprun M; Langdon S; Wang CQ; Adams D; Thiele J; Walker T; Perlee LT; O'Brien MP Ann Allergy Asthma Immunol; 2021 Oct; 127(4):488-495.e5. PubMed ID: 34186172 [TBL] [Abstract][Full Text] [Related]
19. [The correlation between the seasonal variation of house dust mite allergens exposure level in household and the level of asthma control in asthmatic children]. Xiang L; Fu Y; Wang J; Wang Q Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):177-83. PubMed ID: 24824386 [TBL] [Abstract][Full Text] [Related]
20. Effects of house dust mite avoidance measures on Der p 1 concentrations and clinical condition of mild adult house dust mite-allergic asthmatic patients, using no inhaled steroids. Cloosterman SG; Schermer TR; Bijl-Hofland ID; Van Der Heide S; Brunekreef B; Van Den Elshout FJ; Van Herwaarden CL; Van Schayck CP Clin Exp Allergy; 1999 Oct; 29(10):1336-46. PubMed ID: 10520054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]